9Mo·

Purchases this week

I'll cautiously set foot in the door at $GSIT a cautious foot in the door. Here, however, profit-taking could encourage better entries (for additional buying).

In addition to my Nektar $NKTR (-5,41 %) position, I want to expand my biotech/health field. With Tempus $TEM (-7,45 %) and the @BamBamInvest value Procept $PRCT.

05.01
GSI Technology logo
Acheté à 6,73 $US
6
6 Commentaires

image de profil
Apart from $GSIT, I have them all.
‱
1
‱
image de profil
@Multibagger nectar, I'm really excited. It's almost an all or nothing bet. If the 52-week study disappoints, you have to win the lawsuit against Eli Lilly for a second VersuchđŸ˜”â€đŸ’« but I'm in good spirits
‱
1
‱
image de profil
@Darkwingduck I think it will at least double this year.
‱‱
image de profil
@Multibagger If the study is good, then Lutzi will really take off. They will then enter markets worth several billion euros (Dupixent, Rinvoq).
‱
1
‱
image de profil
@Multibagger Have you heard of $LCTX? They've partnered with Roche $ROG for their studies.
‱
1
‱
image de profil
@Darkwingduck never heard
‱‱
Participez Ă  la conversation